| Product Code: ETC7765116 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Neurology Clinical Trials Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Neurology Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Neurology Clinical Trials Market - Industry Life Cycle |
3.4 Jordan Neurology Clinical Trials Market - Porter's Five Forces |
3.5 Jordan Neurology Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.6 Jordan Neurology Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.7 Jordan Neurology Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Jordan Neurology Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Jordan |
4.2.2 Growing investments in healthcare infrastructure and research facilities |
4.2.3 Rising demand for innovative treatments and therapies in neurology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for conducting clinical trials in Jordan |
4.3.2 Limited availability of skilled neurology researchers and clinical trial professionals |
4.3.3 High costs associated with conducting neurology clinical trials in the region |
5 Jordan Neurology Clinical Trials Market Trends |
6 Jordan Neurology Clinical Trials Market, By Types |
6.1 Jordan Neurology Clinical Trials Market, By Phase |
6.1.1 Overview and Analysis |
6.1.2 Jordan Neurology Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F |
6.1.3 Jordan Neurology Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.4 Jordan Neurology Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.5 Jordan Neurology Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.6 Jordan Neurology Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Jordan Neurology Clinical Trials Market, By Study Design |
6.2.1 Overview and Analysis |
6.2.2 Jordan Neurology Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F |
6.2.3 Jordan Neurology Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F |
6.2.4 Jordan Neurology Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F |
6.3 Jordan Neurology Clinical Trials Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Jordan Neurology Clinical Trials Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.3.3 Jordan Neurology Clinical Trials Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Jordan Neurology Clinical Trials Market Revenues & Volume, By Alzheimer's Disease (AD), 2021- 2031F |
6.3.5 Jordan Neurology Clinical Trials Market Revenues & Volume, By Parkinson's Disease (PD), 2021- 2031F |
6.3.6 Jordan Neurology Clinical Trials Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Neurology Clinical Trials Market Import-Export Trade Statistics |
7.1 Jordan Neurology Clinical Trials Market Export to Major Countries |
7.2 Jordan Neurology Clinical Trials Market Imports from Major Countries |
8 Jordan Neurology Clinical Trials Market Key Performance Indicators |
8.1 Patient recruitment rate for neurology clinical trials |
8.2 Time to market approval for neurology therapies |
8.3 Number of partnerships and collaborations with local research institutions |
8.4 Percentage of successful neurology clinical trials conducted |
8.5 Rate of adoption of new technologies in neurology clinical trials |
9 Jordan Neurology Clinical Trials Market - Opportunity Assessment |
9.1 Jordan Neurology Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.2 Jordan Neurology Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.3 Jordan Neurology Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Jordan Neurology Clinical Trials Market - Competitive Landscape |
10.1 Jordan Neurology Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 Jordan Neurology Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here